$JNJ Headlines U.S. stocks head south as oil s
Post# of 102245
Posted On: 01/20/2015 11:27:49 AM
$JNJ Headlines
U.S. stocks head south as oil slides 10:16 a.m. Today - Carla Mozee
J&J shares drop 2.2% for biggest loss among Dow stocks 9:34 a.m. Today - Victor Reklaitis
Mon., Jan. 20: Watch Twitter on India Deal 9:32 a.m. Today - MarketWatch
Morgan Stanley Misses on Q4 Earnings 9:30 a.m. Today - MarketWatch
What happens if the ECB pulls a Swiss-style surprise 9:14 a.m. Today - Barbara Kollmeyer
Updates, advisories and surprises 9:01 a.m. Today - MarketWatch
Delta, Smith & Wesson jump; Morgan Stanley disappoints 8:25 a.m. Today - Victor Reklaitis
Johnson & Johnson beats profit expectations, but sales fall shy 7:59 a.m. Today - Tomi Kilgore
Johnson & Johnson's stock slips 0.3% permarket after Q4 results 7:50 a.m. Today - Tomi Kilgore
Johnson & Johnson Q4 Remicade sales $1.67 vs. FactSet consensus $1.74 7:50 a.m. Today - Tomi Kilgore
Johnson & Johnson Q4 sales down 0.6% to $18.3 bln; FactSet consensus $18.56 bln 7:48 a.m. Today - Tomi Kilgore
Johnson & Johnson net EPS 89 cents vs. $1.23 a year ago 7:47 a.m. Today - Tomi Kilgore
Johnson & Johnson Q4 adj. EPS $1.27 vs. FactSet consensus $1.25 7:46 a.m. Today - Tomi Kilgore
Earnings, ECB highlight holiday-shortened week 2:50 a.m. Jan. 19, 2015 - Tom Bemis
J&J gets grant to speed up Ebola vaccine 8:13 a.m. Jan. 16, 2015 - Chelsey Dulaney
DepoMed to buy U.S. rights to Nucynta from J&J unit 4:48 p.m. Jan. 15, 2015 - Josh Beckerman
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Johnson & Johnson begins humans testing of Ebola vaccine 7:02 a.m. Jan. 6, 2015 - Chelsey Dulaney
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves AbbVie’s hepatitis treatment 3:33 p.m. Dec. 19, 2014 - Peter Loftus
U.S. Stocks Trade Lower 11 min ago - The Wall Street Journal Interactive Edition
Stocks Turn Lower as Oil Takes Sizzle Out of ECB Anticipation 12 min ago - TheStreet.com
Find Your Dividend Yield Sweet Spot 10:11 a.m. Today - Seeking Alpha
Stock Market News for January 20, 2015 - Market News 10:10 a.m. Today - Zacks.com
Johnson & Johnson (JNJ) Stock Falls Today After Lowering 2015 Earnings Forecast 10:07 a.m. Today - TheStreet.com
Dow Jones (DJIA) Today: Coca-Cola (KO) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 10:00 a.m. Today - TheStreet.com
IMF Cuts, Q4 Earnings Mixed - Ahead of Wall Street 9:50 a.m. Today - Zacks.com
J&J (JNJ) Beats on 4Q Earnings but Misses on Revenues - Tale of the Tape 9:00 a.m. Today - Zacks.com
Stock Futures Follow European Markets Higher on ECB Talk 8:27 a.m. Today - TheStreet.com
J&J Sales Dented by Stronger Dollar 8:22 a.m. Today - The Wall Street Journal Interactive Edition
Johnson & Johnson Barely Pulls Through on Strong Pharma Sales 7:47 a.m. Today - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:24 a.m. Today - benzinga.com
Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings 6:44 p.m. Jan. 19, 2015 - TheStreet.com
FDA accepts Janssen's NDA under Priority Review 5:53 p.m. Jan. 19, 2015 - Seeking Alpha
Cosentyx cleared in Europe 5:11 p.m. Jan. 19, 2015 - Seeking Alpha
Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog 11:40 a.m. Jan. 19, 2015 - Zacks.com
Q4 Earnings Take a Breather for MLK Day - Ahead of Wall Street 9:49 a.m. Jan. 19, 2015 - Zacks.com
10 Biggest Deals Involving Venture Capital-Backed Companies in 2014 7:00 a.m. Jan. 19, 2015 - TheStreet.com
Week Ahead: The ECB, Housing Data and Earnings 3:37 p.m. Jan. 16, 2015 - FOXBusiness
Study of Ebola Drug ZMapp Set for West Africa 3:17 p.m. Jan. 16, 2015 - The Wall Street Journal Interactive Edition
InvestorsObserver releases comments on Johnson & Johnson, American Express, Delta Air Lines, Broadcom Corp., and Meritage Homes 9:31 a.m. Today - PR Newswire - PRF
New Provisional Patents Filed for Pharmaceutical Cannabidiol (CBD) Formulation Consisting of Ibuprofen & CBD Compounds Aimed At Treating Pain 8:45 a.m. Today - PR Newswire - PRF
Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results: 7:45 a.m. Today - PR Newswire - PRF
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest U.S. License Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) Oral Solution 4:05 p.m. Jan. 15, 2015 - PR Newswire - PRF
Wearable Technology in Industry Verticals 2014 - 2019 4:45 p.m. Jan. 14, 2015 - PR Newswire - PRF
DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials 9:20 a.m. Jan. 14, 2015 - Marketwired
Tissue Regeneration Systems Adds Business Development Executive 5:00 a.m. Jan. 14, 2015 - PR Newswire - PRF
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:03 a.m. Jan. 13, 2015 - Marketwired
Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:02 a.m. Jan. 13, 2015 - BusinessWire - BZX
Vedanta Biosciences Announces License Agreement with Janssen and Johnson & Johnson Innovation for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
Equities Updates on Health Care Sector - Johnson and Johnson, VIVUS, Actavis, Covance, and Sequenom 8:35 a.m. Jan. 12, 2015 - PR Newswire - PRF
MaRS Innovation Announces Collaboration with Johnson & Johnson Innovation and Janssen to Advance Cardiac, Diabetes and Depression Technologies 8:30 a.m. Jan. 12, 2015 - PR Newswire - PRF
X-Chem Announces Collaboration with Janssen and Johnson & Johnson Innovation to Advance Novel Candidates to Treat Inflammatory Diseases 8:15 a.m. Jan. 9, 2015 - BusinessWire - BZX
Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen 2:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2015 8:45 a.m. Jan. 5, 2015 - PR Newswire - PRF
Zynerba Pharmaceuticals Appoints Richard A. Baron VP and CFO 7:30 a.m. Jan. 5, 2015 - PR Newswire - PRF
Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015 10:01 a.m. Dec. 30, 2014 - ACCESSWIRE
Johnson & Johnson to Participate in 33rd Annual JP Morgan Health Care Conference 8:45 a.m. Dec. 30, 2014 - PR Newswire - PRF
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 4:55 a.m. Dec. 24, 2014 - PR Newswire - PRF
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
U.S. stocks head south as oil slides 10:16 a.m. Today - Carla Mozee
J&J shares drop 2.2% for biggest loss among Dow stocks 9:34 a.m. Today - Victor Reklaitis
Mon., Jan. 20: Watch Twitter on India Deal 9:32 a.m. Today - MarketWatch
Morgan Stanley Misses on Q4 Earnings 9:30 a.m. Today - MarketWatch
What happens if the ECB pulls a Swiss-style surprise 9:14 a.m. Today - Barbara Kollmeyer
Updates, advisories and surprises 9:01 a.m. Today - MarketWatch
Delta, Smith & Wesson jump; Morgan Stanley disappoints 8:25 a.m. Today - Victor Reklaitis
Johnson & Johnson beats profit expectations, but sales fall shy 7:59 a.m. Today - Tomi Kilgore
Johnson & Johnson's stock slips 0.3% permarket after Q4 results 7:50 a.m. Today - Tomi Kilgore
Johnson & Johnson Q4 Remicade sales $1.67 vs. FactSet consensus $1.74 7:50 a.m. Today - Tomi Kilgore
Johnson & Johnson Q4 sales down 0.6% to $18.3 bln; FactSet consensus $18.56 bln 7:48 a.m. Today - Tomi Kilgore
Johnson & Johnson net EPS 89 cents vs. $1.23 a year ago 7:47 a.m. Today - Tomi Kilgore
Johnson & Johnson Q4 adj. EPS $1.27 vs. FactSet consensus $1.25 7:46 a.m. Today - Tomi Kilgore
Earnings, ECB highlight holiday-shortened week 2:50 a.m. Jan. 19, 2015 - Tom Bemis
J&J gets grant to speed up Ebola vaccine 8:13 a.m. Jan. 16, 2015 - Chelsey Dulaney
DepoMed to buy U.S. rights to Nucynta from J&J unit 4:48 p.m. Jan. 15, 2015 - Josh Beckerman
Three investments to own and three to 6:00 a.m. Jan. 13, 2015 - Howard Gold
Johnson & Johnson begins humans testing of Ebola vaccine 7:02 a.m. Jan. 6, 2015 - Chelsey Dulaney
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves AbbVie’s hepatitis treatment 3:33 p.m. Dec. 19, 2014 - Peter Loftus
U.S. Stocks Trade Lower 11 min ago - The Wall Street Journal Interactive Edition
Stocks Turn Lower as Oil Takes Sizzle Out of ECB Anticipation 12 min ago - TheStreet.com
Find Your Dividend Yield Sweet Spot 10:11 a.m. Today - Seeking Alpha
Stock Market News for January 20, 2015 - Market News 10:10 a.m. Today - Zacks.com
Johnson & Johnson (JNJ) Stock Falls Today After Lowering 2015 Earnings Forecast 10:07 a.m. Today - TheStreet.com
Dow Jones (DJIA) Today: Coca-Cola (KO) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 10:00 a.m. Today - TheStreet.com
IMF Cuts, Q4 Earnings Mixed - Ahead of Wall Street 9:50 a.m. Today - Zacks.com
J&J (JNJ) Beats on 4Q Earnings but Misses on Revenues - Tale of the Tape 9:00 a.m. Today - Zacks.com
Stock Futures Follow European Markets Higher on ECB Talk 8:27 a.m. Today - TheStreet.com
J&J Sales Dented by Stronger Dollar 8:22 a.m. Today - The Wall Street Journal Interactive Edition
Johnson & Johnson Barely Pulls Through on Strong Pharma Sales 7:47 a.m. Today - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:24 a.m. Today - benzinga.com
Ebola Vaccine Sends Johnson & Johnson Stock Higher Ahead of Earnings 6:44 p.m. Jan. 19, 2015 - TheStreet.com
FDA accepts Janssen's NDA under Priority Review 5:53 p.m. Jan. 19, 2015 - Seeking Alpha
Cosentyx cleared in Europe 5:11 p.m. Jan. 19, 2015 - Seeking Alpha
Will Pharmaceutical Segment Drive J&J Q4 Earnings Again? - Analyst Blog 11:40 a.m. Jan. 19, 2015 - Zacks.com
Q4 Earnings Take a Breather for MLK Day - Ahead of Wall Street 9:49 a.m. Jan. 19, 2015 - Zacks.com
10 Biggest Deals Involving Venture Capital-Backed Companies in 2014 7:00 a.m. Jan. 19, 2015 - TheStreet.com
Week Ahead: The ECB, Housing Data and Earnings 3:37 p.m. Jan. 16, 2015 - FOXBusiness
Study of Ebola Drug ZMapp Set for West Africa 3:17 p.m. Jan. 16, 2015 - The Wall Street Journal Interactive Edition
InvestorsObserver releases comments on Johnson & Johnson, American Express, Delta Air Lines, Broadcom Corp., and Meritage Homes 9:31 a.m. Today - PR Newswire - PRF
New Provisional Patents Filed for Pharmaceutical Cannabidiol (CBD) Formulation Consisting of Ibuprofen & CBD Compounds Aimed At Treating Pain 8:45 a.m. Today - PR Newswire - PRF
Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results: 7:45 a.m. Today - PR Newswire - PRF
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest U.S. License Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) Oral Solution 4:05 p.m. Jan. 15, 2015 - PR Newswire - PRF
Wearable Technology in Industry Verticals 2014 - 2019 4:45 p.m. Jan. 14, 2015 - PR Newswire - PRF
DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials 9:20 a.m. Jan. 14, 2015 - Marketwired
Tissue Regeneration Systems Adds Business Development Executive 5:00 a.m. Jan. 14, 2015 - PR Newswire - PRF
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:03 a.m. Jan. 13, 2015 - Marketwired
Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:02 a.m. Jan. 13, 2015 - BusinessWire - BZX
Vedanta Biosciences Announces License Agreement with Janssen and Johnson & Johnson Innovation for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
Equities Updates on Health Care Sector - Johnson and Johnson, VIVUS, Actavis, Covance, and Sequenom 8:35 a.m. Jan. 12, 2015 - PR Newswire - PRF
MaRS Innovation Announces Collaboration with Johnson & Johnson Innovation and Janssen to Advance Cardiac, Diabetes and Depression Technologies 8:30 a.m. Jan. 12, 2015 - PR Newswire - PRF
X-Chem Announces Collaboration with Janssen and Johnson & Johnson Innovation to Advance Novel Candidates to Treat Inflammatory Diseases 8:15 a.m. Jan. 9, 2015 - BusinessWire - BZX
Johnson & Johnson Announces Start of Phase 1 Clinical Trial of Ebola Vaccine Regimen 2:00 a.m. Jan. 6, 2015 - PR Newswire - PRF
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2015 8:45 a.m. Jan. 5, 2015 - PR Newswire - PRF
Zynerba Pharmaceuticals Appoints Richard A. Baron VP and CFO 7:30 a.m. Jan. 5, 2015 - PR Newswire - PRF
Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015 10:01 a.m. Dec. 30, 2014 - ACCESSWIRE
Johnson & Johnson to Participate in 33rd Annual JP Morgan Health Care Conference 8:45 a.m. Dec. 30, 2014 - PR Newswire - PRF
Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 4:55 a.m. Dec. 24, 2014 - PR Newswire - PRF
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼